Drug Profile
YAR 1515
Alternative Names: YAR-1515Latest Information Update: 15 Jul 2016
Price :
$50
*
At a glance
- Originator Yung-Jin Pharmaceutical
- Class Antiallergics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Rhinitis
Most Recent Events
- 30 Sep 2015 Launched for Rhinitis (unspecified route) before September 2015